pharmaphorum

NOVEMBER 1, 2021

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as a treatment for malignant glioma, an aggressive form of brain cancer. million yen (around $12,500) per dose, according to a Pharma Japan report.

Genetic Engineering 122

Genetic Engineering Clinical Trials Clinical Trials Trials 122

Pharmaceutical Technology

MAY 2, 2023

There are more than 20 marketed ICIs with approvals across a very wide spectrum of solid tumour indications. Chimeric antigen receptor T-cell (CAR-T) therapies are the only genetically modified cell therapies to have received regulatory approval, and they are currently utilised in relapsed/refractory settings.

Genetic Engineering 130

Genetic Engineering Antibody Clinical Trials Clinical Trials 130

BioTech 365

SEPTEMBER 8, 2020

-Genetically engineered therapy treats relapsed or refractory large B-cell lymphoma, a blood cancer- MILWAUKEE–(BUSINESS WIRE)–The CIBMTR® (Center for International Blood and Marrow Transplant Research®) today announced that it has reached a study enrollment goal 2 years early, and 1,500 patients … Continue reading → (..)

Genetic Engineering 40

Genetic Engineering Engineer Genetics Marketing 40

Pharmaceutical Technology

FEBRUARY 15, 2023

Innovation S-curve for the pharmaceutical industry Gene splicing using nucleases is a key innovation area in the pharmaceutical industry Nucleases play a fundamental role in the field of recombinant DNA technology, or genetic engineering. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.

Gene Splicing 130

Gene Splicing Gene DNA Recombinant DNA Technology 130

pharmaphorum

JANUARY 19, 2021

Marketed as Tecartus (autologous anti-CD19-transduced CD3+) in Europe, the drug was approved in the EU in December for adults with relapsed or refractory mantle cell lymphoma after two or more lines of systemic therapy including a Bruton’s tyrosine kinase (BTK) inhibitor.

Genetic Engineering 73

Genetic Engineering Engineer Genetics Drugs 73

pharmaphorum

AUGUST 23, 2021

DNA vaccines work by delivering a genetically-engineered plasmid containing the DNA sequence encoding the desired antigen – in this case the SARS-CoV-2 spike protein – which is then taken up by cells.

DNA 98

DNA Vaccine Vaccination Genetic Engineering 98

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

pharmaphorum

MAY 7, 2021

CRISPR’s deal with Nkarta aims to create genetically engineered NK cells, which are harvested and used to create a bank of “off the shelf” cells that can administered to patients like a drug. CRISPR Therapeutics and Nkarta will equally share all R&D costs and profits worldwide related to the collaboration.

Gene Editing 52

Gene Editing Gene Genetic Engineering DNA 52

Pharmaceutical Technology

APRIL 5, 2023

More than a decade after the first patient was treated with a CAR-T therapy, six therapies relying on the same principles have been approved by the US Food and Drug Administration (FDA) and marketed to thousands of patients. Exa-cel is almost certainly going to the first CRISPR engineered product [to be approved].

Gene Therapy 147

Gene Therapy Gene Engineer Production 147

Roots Analysis

MARCH 16, 2023

The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering. What are the key trends that are shaping up the mRNA therapeutics and vaccines market? mRNA-based therapeutics and vaccines can be delivered via the below-mentioned approaches.

Vaccine 52

Vaccine Vaccination DNA Protein 52

The Pharma Data

JANUARY 17, 2021

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Media Contact: Kelly Owen Grover Director of Marketing Communications 518-478-6095 kelly.grover@taconic.com . Source link.

Genetic Engineering 40

Genetic Engineering Genetics Engineer Immune Response 40

Roots Analysis

FEBRUARY 13, 2023

It transfers genetic information form to DNA to ribosomes, a specialized structure, or organelle, which decodes genetic information into a protein. With the help of genetic engineering, synthetic mRNAs can express proteins, as they structurally resemble a natural mRNA.

Manufacturing 52

Manufacturing Drug Delivery Systems Genetic Engineering RNA 52

Roots Analysis

FEBRUARY 15, 2022

Gene engineering based on recombination was pioneered in the mid-1990s; Currently, development of gene editing technologies has opened up the possibility of modifying genomic sequences in both eukaryotic and prokaryotic organisms. Bringing in Light Genome Editing Techniques: ZFN, TALEN and Meganucleases. Our Social Media Platform.

Genome 52

Genome Genomics Gene Editing DNA 52

Advarra

JUNE 13, 2023

Research in gene therapies and genetically engineered drugs and vaccines are growing exponentially, and will only continue to become more popular. The accelerating gene therapy market is expected to grow globally by 16.6% between 2020-2027.

Gene Therapy 52

Gene Therapy Gene Research Genetic Engineering 52

pharmaphorum

SEPTEMBER 13, 2022

Thanks to the dedicated efforts of doctors, patients, carers, and healthcare professionals, people diagnosed with blood cancer are now living longer, with a steady stream of more effective treatments entering the market each year. 2016–2022 — New treatments enter the market. 1832 – Discovery of Hodgkin’s and non-Hodgkin’s lymphoma.

Genome Project 98

Genome Project Genomics Genome DNA 98

XTalks

MARCH 6, 2024

This includes discussions on cutting-edge technologies and methodologies in brain research, such as neuroimaging, genetic engineering and artificial intelligence. Key market segments include drug types like antiepileptic, antipsychotic, antidepressant, cholinesterase inhibitors and NMDA receptor antagonists. percent.

FDA Approval 69

FDA Approval In-Vitro Research Marketing 69

Cloudbyz

MARCH 5, 2024

Market Exclusivity and Patents: Biologics are often protected by strong patent laws and regulatory data protection, which can provide longer periods of market exclusivity compared to small molecules. Such support can reduce the time and cost associated with bringing a new biologic to market.

Development 97

Development Drugs Immune Response Manufacturing 97

Advarra

JANUARY 11, 2024

Some of these approaches involve directly isolating the patient’s immune cells and simply expanding their quantity, while other treatments involve genetically engineering their immune cells to enhance cancer-fighting capabilities. Only after these trials are successful can sponsors seek market approval for mRNA-based products.

Vaccination 52

Vaccination Vaccine Protein Antibody 52

The Pharma Data

MARCH 29, 2022

In a preprint, the researchers at Cornell University led by Associate Professor Hector Aguilar-Carreno showed that genetically engineered mice infected with the virus causing COVID-19 and given a daily dose of the compound in a nasal spray for four days. WThe big picture is, there are multiple steps in the life cycle of a virus.

Genetic Engineering 52

Genetic Engineering Research Genetics Drugs 52

The Pharma Data

OCTOBER 26, 2020

These mAbs are already of human origin and functionally optimized for high potency by the donor’s immune system; hence, they technically do not require genetic engineering or further optimization to achieve full functionality.

Antibody 52

Antibody Genetic Engineering Development Clinical Trials 52

The Pharma Data

JULY 27, 2021

Teneobio’s discovery platform, TeneoSeek, comprises genetically engineered animals (UniRat® and OmniFlic®), next-generation sequencing, bioinformatics and high-throughput vector assembly technologies. About Teneobio Teneobio, Inc.

Production 52

Production Antibody Sales Development 52

pharmaphorum

NOVEMBER 2, 2021

Dr Laura Moriarty, senior marketing manager at Bio-Rad, looks at the impressive immuno-therapeutic potential of bispecific antibodies (bsAbs). Though advances in genetic engineering have greatly supported high-producing cell lines, the successful development of bsAbs at scale relies on the genetic stability of such lines.

Antibody 52

Antibody Immune Response Production Engineer 52

Roots Analysis

OCTOBER 22, 2023

It is important to highlight that IVT mRNAs are structurally similar to natural mRNAs and can be used to express proteins through genetic engineering. In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent.

RNA 40

RNA Protein Genetics Gene Expression 40

The Pharma Data

APRIL 27, 2023

It is also an off-the-shelf therapy, meaning that people do not have to wait for cell collection and genetic engineering before starting treatment, which could be particularly important for patients who are at a high-risk of their disease progressing. A final decision is expected from the European Commission (EC) in the near future.

Genetic Engineering 40

Genetic Engineering Clinical Development Antibody Medicine 40

Roots Analysis

SEPTEMBER 9, 2024

Algal Expression System: This expression system is used in genetic engineering, biofuel production, botany. To date, she has contributed to over five full length market research projects. It offers excellent experimental control for nutraceuticals and biofuel.

Protein 40

Protein Gene Production DNA 40

The Pharma Data

NOVEMBER 4, 2020

. Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides.

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

SEPTEMBER 8, 2020

Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs. For more information, visit. www.novavax.com. and connect with us on.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

OCTOBER 27, 2020

The decrease in Adcirca revenues was driven by continued erosion of market share due to generic competition. Sales and marketing. Cash, cash equivalents, and marketable investments. Cost of product sales. Dollar Change. .

Production 40

Production Sales Licensing Licensing 40

XTalks

SEPTEMBER 15, 2022

According to the order, it will improve and expand biomanufacturing production capacity and processes, train a biotech workforce, expand market opportunities for these products and streamline regulation. The federal law that mandates some genetically modified (GM) food and beverage items to be labeled calls them “bioengineered.”

FDA Approval 95

FDA Approval Genetic Engineering Genetics Production 95

Roots Analysis

JANUARY 27, 2025

Within microbial fermentation market, service providers presently claim to have most of the microbial production capacity, driving innovators to outsource their manufacturing needs and shift their focus on research and development efforts. Key Trends in the Microbial CMO Market A.

Marketing 40

Marketing Manufacturing Production Development 40

XTalks

DECEMBER 3, 2024

Diabetes affects millions worldwide, and the pharmaceutical market is responding with treatments that not only improve glycemic control but also address cardiovascular and kidney-related complications, offering holistic management for patients. The first genetically engineered human insulin , Humulin , was introduced in 1982.

Sales 105

Sales Insulin FDA Approval Drugs 105

Pharmaceutical Technology

JUNE 16, 2023

According to GlobalData, cell therapies have been transformational in the immune oncology space, with chimeric antigen receptor T-cell (CAR-T) therapies like TT11X being genetically modified cell therapies to have received regulatory approval. Please check your email to download the Report.

Genetic Engineering 130

Genetic Engineering Genetics Trials Engineer 130

FDA Law Blog

SEPTEMBER 16, 2022

The Executive Order also mentions the need to develop genetic engineering technologies and techniques and advance the science of scale-up production so that innovative technologies and products can reach markets faster. We’ve only touched on a few of the objectives identified in this ambitious and all-encompassing order.

Manufacturing 75

Manufacturing Genetic Engineering Production Development 75